Bromodomain Inhibition Blocks Inflammation-Induced Cardiac Dysfunction and SARS-CoV2 Infection in Pre-Clinical Models
Preprint posted on October 16, 2020 https://doi.org/10.1101/2020.08.23.258574
‘In the eye of the (Cytokine) Storm’: COVID-19 inflammation and heart function in 3D-engineered cardiac tissues
Selected by Alexander Ward, Osvaldo ContrerasBackground
The ongoing novel coronavirus (SARS-CoV-2) pandemic has infected over 60 million people worldwide, with more than 1.4 million fatalities1. Aside from the occurrence of well-characterised respiratory symptoms of coronavirus disease (COVID-19), 20-50% affected patients are presenting with cardiac complications, including myocarditis (inflammation of the heart), cardiac cell death, heart failure (acute and chronic types) and arrhythmias2.
The reasons for the increased cardiac complications in COVID-19, as compared with other coronavirus diseases, are as yet unknown. It has been speculated that both direct and indirect consequences of infection contribute to diverse cardiac pathologies. With respect to the direct consequences, SARS-CoV-2 shows a significantly greater affinity for its primary target, the angiotensin-converting enzyme 2 (ACE2) receptor, than SARS-CoV-1, potently and directly targeting cardiac tissues high in ACE22. Exactly which cells of the heart SARS-CoV-2 affects remains unclear; however, direct infection of cardiomyocytes, the beating muscular, conducting cells, has also been observed3. In addition to direct effects on cardiomyocytes, the secondary inflammatory response and increased clotting risk associated with COVID-19 are thought to damage cardiac tissue indirectly 2. In severe cases, acute systemic inflammation induces a ‘Cytokine Storm’, the effects and composition of which are poorly understood.
Despite the recent news of efficacy of a number of novel COVID-19 vaccines4,5, treatments which can alleviate the secondary symptoms remain behind vaccination efforts. Anti-inflammatory agents, inhibiting diverse inflammatory pathways, have made it to clinical trials; the corticosteroid, Dexamethasone, has been shown to reduce mortality in ventilated patients6.
Given the difficulties of studying the effects of SARS-CoV-2 on the human heart and the sheer speed of dissemination of COVID-19 related preprints, there is a necessity to quickly understand the molecular mechanisms of the disease firstly in an in vitro setting. The Hudson laboratory are world leaders in the generation of high-throughput bioengineered heart tissues (human cardiac organoids: hCO), using induced pluripotent stem cell (iPSC)-derived cardiac cells and their patented Heart-Dyno system7. Their system provides them with a unique opportunity to screen vast numbers of exogenous molecules and therapeutics, in mature cardiac-like tissues8, and, due to spontaneous beating, measure functional contractile parameters comparable to those measured in the heart. In the current preprint, Mills et al., use their tissue engineered hCO model to address the effects of the cytokine storm on cardiac function and cardiac cell composition following stimulation.

Key findings
Much like the adult human heart, the dynamic, beating hCO tissues include diverse cardiac cell-types, including cardiomyocytes, endothelial cells, fibroblasts and pericytes. Using single nuclei RNA-seq (snRNA-seq), Mills et al. showed that the expression levels of several proinflammatory genes linked to the cytokine storm were very similar to those seen in the human heart. Using their high-throughput system, they next screened several pro-inflammatory factors, including cytokines, TNFa, IL-1b, IL-6, IL-8, IL-8, IL-17 and IFN-g, and pathogen associated molecule polyIC and LPS. A number of the components of the cytokine storm resulted in profound alterations to cardiac function in stimulated hCOs. TNFa induced a broad reduction in force (equating to systolic dysfunction), as has been suggested previously9. Whilst IL-1b, IFN-g and polyIC caused an increase in the relaxation time of tissues in between beats, which is clinically representative of diastolic dysfunction in heart failure, where the left ventricle fails to relax normally. This prolonged relaxation time of their cardiac tissues also resulted in an arrhythmic beating, a manifestation which is commonly seen in COVID-19 patients.
Video 1. Spontaneously contracting hCO, beating against the poles of the Heart Dyno. Credit to Richard J Mills.
The profound effects of the cytokine storm on cardiac dysfunction led the authors to investigate the potential downstream effectors of this inflammatory response in heart tissue. Given the critical role of phosphoproteins in transducing inflammatory signals, they interrogated the phosphoproteome using the high-sensitivity EasyPhos technique. The authors identified many differentially phosphorylated effectors, which included transcription factors and chromatin-binding proteins, as well as a handful of other transcription-related machinery, including STAT1 and BRD4. Many of these effectors appeared to be involved in cell proliferation. Upon cytokine storm stimulation, there was a shift in cell populations; fibroblasts became more activated, and cardiomyocyte populations were drastically altered. This activated, proliferative signature hint that the cytokine storm may be inducing cell-fate changes in cardiac tissue, possibly predisposing to heart failure-like cardiac dysfunction.
Next, Mills and colleagues performed a drug screening of potential small molecules that could prevent cardiac dysfunction after TNFa and cytokine storm-driven diastolic dysfunction. The authors provide evidence that suggests a protective role for the CDK8 inhibitors SEL120-34A and BI-1347 in cardiac dysfunction. Having observed induced phosphorylation of the Bromo- and Extra-Terminal domain (BET) family member BRD4 following cytokine storm exposure, they evaluated the potential protective role of BET inhibitors against cytokine storm-derived cardiac dysfunction. Among them, INCB054329 was the most effective in preventing cytokine storm-induced diastolic dysfunction, and remarkably, it also prevented diastolic dysfunction caused by COVID-19 patient serum with high CTNI and BPN, but not with low levels of these cardiac-derived proteins.
In order to recapitulate the cytokine storm observed in humans following SARS-CoV-2 infection and translate these previous findings into a clinically relevant animal model, the authors utilized a murine model of lipopolysaccharide (LPS)-induced inflammation. The treatment with INCB054329 BRD inhibitor blocked the LPS-mediated inflammation and also restricted the LPS-induced fibrotic response of fibroblasts. Remarkably, the BRD inhibitor also extended the life of LPS-challenged mice. Overall, these data suggest that INCB054329 represents a potent, robust and promising small molecule BRD inhibitor for improving cardiac function and cytokine storm-mediated mortality.
Using 2D cultured human-induced pluripotent stem cell derived cardiomyocytes, the authors also indicated that INCB054329 protects cardiac cells against SARS-CoV-2 infection and sarcomere degradation. Owing to the fact that the BRD inhibitor reduced the expression of ACE2, the authors speculated that reduced viral infiltration could be the cause for diminished viral load and infection in response to INCB054329 treatment. These favourable findings suggest that pre-treatment with BRD inhibitors could protect patients’ hearts against SARS-CoV-2 infection.
Why we chose this preprint and what we liked about it
Following on from our first prelight (https://doi.org/10.1242/prelights.23879), which addressed the role of BRD4 inhibition on the reversion of activated cardiac fibroblasts in ischaemic and hypertrophic mouse injury models, the current preprint used a similar approach to treat the COVID-19-induced cytokine storm. Here, Mills and colleagues demonstrated that BRD4 inhibition prevented fibroblast activation and cardiac dysfunction in response to the cytokine storm, in their hCO model, arriving at similar conclusions to the study from the Haldar and Srivastava laboratories10. The comprehensive efficacy of BRD4 inhibition in treating cardiac dysfunction in these two studies makes the recent preprints highly complementary and extremely exciting for the field.
This preprint utilises state-of-the-art techniques in conjunction with the unique Heart Dyno system developed in the Hudson lab, to address the critical question of how heart function can be affected directly and indirectly by SARS-CoV-2 infection. They have been able to elegantly and quickly identify a combination of cytokines with profound effects on the function of their heart tissues, as well as establish effective potential therapeutics to ameliorate cytokine-induced cardiac dysfunction. The assay-throughput and functional similarity of the hCO system to the adult heart are huge strengths of this study. As such, this preprint represents an important step in furthering our understanding of the mechanisms of COVID-19 in the heart.
Posted on: 27th November 2020
doi: https://doi.org/10.1242/prelights.25933
Read preprintSign up to customise the site to your preferences and to receive alerts
Register hereAlso in the bioengineering category:
Also in the bioinformatics category:
Dissecting Mammalian Spermatogenesis Using Spatial Transcriptomics
Selected by | Martin Estermann |
The hourglass model of evolutionary conservation during embryogenesis extends to developmental enhancers with signatures of positive selection
Selected by | Irepan Salvador-Martinez |
1
The mutational landscape of human somatic and germline cells
Selected by | Kerryn Elliott |
Also in the clinical trials category:
Bromodomain Inhibition Blocks Inflammation-Induced Cardiac Dysfunction and SARS-CoV2 Infection in Pre-Clinical Models
Selected by | Alexander Ward, Osvaldo Contreras |
1
Decoding distinctive features of plasma extracellular vesicles in amyotrophic lateral sclerosis
Selected by | Kristina Kuhbandner |
1
A Transcriptional Switch Governing Fibroblast Plasticity Underlies Reversibility of Chronic Heart Disease
Selected by | Osvaldo Contreras, Alexander Ward |
Also in the genomics category:
Dissecting Mammalian Spermatogenesis Using Spatial Transcriptomics
Selected by | Martin Estermann |
EccDNA formation is dependent on MMEJ, repressed by c-NHEJ pathway, and stimulated by DNA double-strand break
Selected by | Ram |
1
Association analysis of repetitive elements and R-loop formation across species
Selected by | Ram |
1
Also in the molecular biology category:
GAK and PRKCD are positive regulators of PRKN-independent mitophagy
Selected by | Kirsty Hooper |
1
Epigenetic control of coordinated hematopoietic and cardiovascular development by Rnf2 in zebrafish
Selected by | Tim Petzold |
1
Dissecting Mammalian Spermatogenesis Using Spatial Transcriptomics
Selected by | Martin Estermann |
Also in the pharmacology and toxicology category:
Bacteriological and histopathological findings in cetaceans that stranded in the Philippines from 2017 to 2018
Selected by | Paul Gerald L. Sanchez and Stefano Vianello |
2
Bromodomain Inhibition Blocks Inflammation-Induced Cardiac Dysfunction and SARS-CoV2 Infection in Pre-Clinical Models
Selected by | Alexander Ward, Osvaldo Contreras |
1
Accelerated erythrocyte senescence causes dose-limiting anemia of antimalarial enolase inhibitors
Selected by | Zhang-He Goh |
Also in the physiology category:
Intraspecific variation in thermal tolerance differs between tropical and temperate fishes
Selected by | Charlotte Nelson |
Dissecting Mammalian Spermatogenesis Using Spatial Transcriptomics
Selected by | Martin Estermann |
Sick Bats Stay Home Alone: Social distancing during the acute phase response in Egyptian fruit bats (Rousettus aegyptiacus)
Selected by | Baheerathan Murugavel |
Also in the systems biology category:
Downstream of gasdermin D cleavage, a Ragulator-Rag-mTORC1 pathway promotes pore formation and pyroptosis
Selected by | Connor Rosen |
Bromodomain Inhibition Blocks Inflammation-Induced Cardiac Dysfunction and SARS-CoV2 Infection in Pre-Clinical Models
Selected by | Alexander Ward, Osvaldo Contreras |
1
Generative modeling of single-cell population time series for inferring cell differentiation landscapes
Selected by | Yen-Chung Chen |
preListsbioengineering category:
in the3D Gastruloids
A curated list of preprints related to Gastruloids (in vitro models of early development obtained by 3D aggregation of embryonic cells). Preprint missing? Don't hesitate to let us know.
List by | Paul Gerald L. Sanchez and Stefano Vianello |
ASCB EMBO Annual Meeting 2019
A collection of preprints presented at the 2019 ASCB EMBO Meeting in Washington, DC (December 7-11)
List by | Madhuja Samaddar, Ramona Jühlen, Amanda Haage, Laura McCormick, Maiko Kitaoka |
EMBL Seeing is Believing – Imaging the Molecular Processes of Life
Preprints discussed at the 2019 edition of Seeing is Believing, at EMBL Heidelberg from the 9th-12th October 2019
List by | Dey Lab |
Lung Disease and Regeneration
This preprint list compiles highlights from the field of lung biology.
List by | Rob Hynds |
Advances in microscopy
This preList highlights exciting unpublished preprint articles describing advances in microscopy with a focus on light-sheet microscopy.
List by | Stephan Daetwyler |
Also in the bioinformatics category:
Single Cell Biology 2020
A list of preprints mentioned at the Wellcome Genome Campus Single Cell Biology 2020 meeting.
List by | Alex Eve |
Antimicrobials: Discovery, clinical use, and development of resistance
Preprints that describe the discovery of new antimicrobials and any improvements made regarding their clinical use. Includes preprints that detail the factors affecting antimicrobial selection and the development of antimicrobial resistance.
List by | Zhang-He Goh |
Also in the clinical trials category:
Also in the genomics category:
EMBL Conference: From functional genomics to systems biology
Preprints presented at the virtual EMBL conference "from functional genomics and systems biology", 16-19 November 2020
List by | Jesus Victorino |
TAGC 2020
Preprints recently presented at the virtual Allied Genetics Conference, April 22-26, 2020. #TAGC20
List by | Maiko Kitaoka, Madhuja Samaddar, Miguel V. Almeida, Sejal Davla, Jennifer Ann Black, Dey Lab |
Zebrafish immunology
A compilation of cutting-edge research that uses the zebrafish as a model system to elucidate novel immunological mechanisms in health and disease.
List by | Shikha Nayar |
Also in the molecular biology category:
FENS 2020
A collection of preprints presented during the virtual meeting of the Federation of European Neuroscience Societies (FENS) in 2020
List by | Ana Dorrego-Rivas |
ECFG15 – Fungal biology
Preprints presented at 15th European Conference on Fungal Genetics 17-20 February 2020 Rome
List by | Hiral Shah |
ASCB EMBO Annual Meeting 2019
A collection of preprints presented at the 2019 ASCB EMBO Meeting in Washington, DC (December 7-11)
List by | Madhuja Samaddar, Ramona Jühlen, Amanda Haage, Laura McCormick, Maiko Kitaoka |
Lung Disease and Regeneration
This preprint list compiles highlights from the field of lung biology.
List by | Rob Hynds |
MitoList
This list of preprints is focused on work expanding our knowledge on mitochondria in any organism, tissue or cell type, from the normal biology to the pathology.
List by | Sandra Franco Iborra |
Also in the pharmacology and toxicology category:
FENS 2020
A collection of preprints presented during the virtual meeting of the Federation of European Neuroscience Societies (FENS) in 2020
List by | Ana Dorrego-Rivas |
COVID-19 / SARS-CoV-2 preprints
List of important preprints dealing with the ongoing coronavirus outbreak. See http://covidpreprints.com for additional resources and timeline, and https://connect.biorxiv.org/relate/content/181 for full list of bioRxiv and medRxiv preprints on this topic
List by | Dey Lab, Zhang-He Goh |
1
Drug use in special populations
Any drugs that are being used in special populations: Patients with liver and kidney failure, in paediatrics, in geriatrics, and in pregnant or lactating patients. Includes the discovery of factors that could potentially affect drug use in these special populations.
List by | Zhang-He Goh |
Toxicology of toxicants, existing therapeutics, and investigational drugs
Preprints that describe the toxicology of environmental pollutants and existing and upcoming drugs. Includes both toxicokinetics and toxicodynamics, as well as technological improvements that will help in the characterisation of this field.
List by | Zhang-He Goh |
Antimicrobials: Discovery, clinical use, and development of resistance
Preprints that describe the discovery of new antimicrobials and any improvements made regarding their clinical use. Includes preprints that detail the factors affecting antimicrobial selection and the development of antimicrobial resistance.
List by | Zhang-He Goh |
Anticancer agents: Discovery and clinical use
Preprints that describe the discovery of anticancer agents and their clinical use. Includes both small molecules and macromolecules like biologics.
List by | Zhang-He Goh |
Advances in Drug Delivery
Advances in formulation technology or targeted delivery methods that describe or develop the distribution of small molecules or large macromolecules to specific parts of the body.
List by | Zhang-He Goh |
Also in the physiology category:
FENS 2020
A collection of preprints presented during the virtual meeting of the Federation of European Neuroscience Societies (FENS) in 2020
List by | Ana Dorrego-Rivas |
TAGC 2020
Preprints recently presented at the virtual Allied Genetics Conference, April 22-26, 2020. #TAGC20
List by | Maiko Kitaoka, Madhuja Samaddar, Miguel V. Almeida, Sejal Davla, Jennifer Ann Black, Dey Lab |
Autophagy
Preprints on autophagy and lysosomal degradation and its role in neurodegeneration and disease. Includes molecular mechanisms, upstream signalling and regulation as well as studies on pharmaceutical interventions to upregulate the process.
List by | Sandra Malmgren Hill |
Cellular metabolism
A curated list of preprints related to cellular metabolism at Biorxiv by Pablo Ranea Robles from the Prelights community. Special interest on lipid metabolism, peroxisomes and mitochondria.
List by | Pablo Ranea Robles |
Also in the systems biology category:
Single Cell Biology 2020
A list of preprints mentioned at the Wellcome Genome Campus Single Cell Biology 2020 meeting.
List by | Alex Eve |
ASCB EMBO Annual Meeting 2019
A collection of preprints presented at the 2019 ASCB EMBO Meeting in Washington, DC (December 7-11)
List by | Madhuja Samaddar, Ramona Jühlen, Amanda Haage, Laura McCormick, Maiko Kitaoka |
EMBL Seeing is Believing – Imaging the Molecular Processes of Life
Preprints discussed at the 2019 edition of Seeing is Believing, at EMBL Heidelberg from the 9th-12th October 2019
List by | Dey Lab |
Pattern formation during development
The aim of this preList is to integrate results about the mechanisms that govern patterning during development, from genes implicated in the processes to theoritical models of pattern formation in nature.
List by | Alexa Sadier |